Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Contrasting roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus: MKNK1 facilitates cell entry.

Kim S, Ishida H, Yamane D, Yi M, Swinney DC, Foung S, Lemon SM.

J Virol. 2013 Apr;87(8):4214-24. doi: 10.1128/JVI.00954-12. Epub 2013 Jan 30.

2.

AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets.

Neveu G, Ziv-Av A, Barouch-Bentov R, Berkerman E, Mulholland J, Einav S.

J Virol. 2015 Apr;89(8):4387-404. doi: 10.1128/JVI.02705-14. Epub 2015 Feb 4.

3.

Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.

Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, Simon FR.

Biochem J. 2004 Mar 15;378(Pt 3):919-28. Erratum in: Biochem J. 2004 Jul 1;381(Pt 3):951.

4.

Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway.

Pei R, Zhang X, Xu S, Meng Z, Roggendorf M, Lu M, Chen X.

Virol Sin. 2012 Oct;27(5):278-85. doi: 10.1007/s12250-012-3257-6. Epub 2012 Sep 21.

PMID:
23001481
5.

Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening.

Supekova L, Supek F, Lee J, Chen S, Gray N, Pezacki JP, Schlapbach A, Schultz PG.

J Biol Chem. 2008 Jan 4;283(1):29-36. Epub 2007 Oct 19.

6.

PI4K-beta and MKNK1 are regulators of hepatitis C virus IRES-dependent translation.

Lupberger J, Casanova C, Fischer B, Weiss A, Fofana I, Fontaine N, Fujiwara T, Renaud M, Kopp A, Schuster C, Brino L, Baumert TF, Thoma C.

Sci Rep. 2015 Sep 1;5:13344. doi: 10.1038/srep13344.

7.

Pim Kinase Interacts with Nonstructural 5A Protein and Regulates Hepatitis C Virus Entry.

Park C, Min S, Park EM, Lim YS, Kang S, Suzuki T, Shin EC, Hwang SB.

J Virol. 2015 Oct;89(19):10073-86. doi: 10.1128/JVI.01707-15. Epub 2015 Jul 22.

8.

Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner.

Shao RX, Zhang L, Peng LF, Sun E, Chung WJ, Jang JY, Tsai WL, Hyppolite G, Chung RT.

J Virol. 2010 Jun;84(12):6060-9. doi: 10.1128/JVI.02484-09. Epub 2010 Apr 7.

9.

Modulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core protein.

Ngo HT, Pham LV, Kim JW, Lim YS, Hwang SB.

J Virol. 2013 May;87(10):5718-31. doi: 10.1128/JVI.03353-12. Epub 2013 Mar 13.

10.

Polo-like kinase 1 is involved in hepatitis C virus replication by hyperphosphorylating NS5A.

Chen YC, Su WC, Huang JY, Chao TC, Jeng KS, Machida K, Lai MM.

J Virol. 2010 Aug;84(16):7983-93. doi: 10.1128/JVI.00068-10. Epub 2010 Jun 9.

11.

CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R.

Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.

PMID:
22814930
12.

Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle.

Li Q, Zhang YY, Chiu S, Hu Z, Lan KH, Cha H, Sodroski C, Zhang F, Hsu CS, Thomas E, Liang TJ.

PLoS Pathog. 2014 May 22;10(5):e1004163. doi: 10.1371/journal.ppat.1004163. eCollection 2014 May.

13.

The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Goto K, Lin W, Zhang L, Jilg N, Shao RX, Schaefer EA, Zhao H, Fusco DN, Peng LF, Kato N, Chung RT.

J Hepatol. 2013 Nov;59(5):942-8. doi: 10.1016/j.jhep.2013.06.025. Epub 2013 Jul 2.

14.

Comparison of U2OS and Huh-7 cells for identifying host factors that affect hepatitis C virus RNA replication.

Jones DM, Domingues P, Targett-Adams P, McLauchlan J.

J Gen Virol. 2010 Sep;91(Pt 9):2238-48. doi: 10.1099/vir.0.022210-0. Epub 2010 May 26.

PMID:
20505011
15.

Identification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assembly.

Neveu G, Barouch-Bentov R, Ziv-Av A, Gerber D, Jacob Y, Einav S.

PLoS Pathog. 2012;8(8):e1002845. doi: 10.1371/journal.ppat.1002845. Epub 2012 Aug 16.

16.

Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.

Saito K, Shirasago Y, Suzuki T, Aizaki H, Hanada K, Wakita T, Nishijima M, Fukasawa M.

J Virol. 2015 Feb;89(4):2220-32. doi: 10.1128/JVI.03385-14. Epub 2014 Dec 3.

17.

Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.

Florimond A, Chouteau P, Bruscella P, Le Seyec J, Mérour E, Ahnou N, Mallat A, Lotersztajn S, Pawlotsky JM.

Gut. 2015 Jun;64(6):957-65. doi: 10.1136/gutjnl-2013-305634. Epub 2014 Jul 25.

PMID:
25063678
18.

Dissecting the roles of the 5' exoribonucleases Xrn1 and Xrn2 in restricting hepatitis C virus replication.

Li Y, Yamane D, Lemon SM.

J Virol. 2015 May;89(9):4857-65. doi: 10.1128/JVI.03692-14. Epub 2015 Feb 11.

19.

Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.

Trotard M, Lepère-Douard C, Régeard M, Piquet-Pellorce C, Lavillette D, Cosset FL, Gripon P, Le Seyec J.

FASEB J. 2009 Nov;23(11):3780-9. doi: 10.1096/fj.09-131920. Epub 2009 Jul 16.

PMID:
19608626
20.

Hepatitis C virus entry: role of host and viral factors.

Samreen B, Khaliq S, Ashfaq UA, Khan M, Afzal N, Shahzad MA, Riaz S, Jahan S.

Infect Genet Evol. 2012 Dec;12(8):1699-709. doi: 10.1016/j.meegid.2012.07.010. Epub 2012 Aug 2. Review.

PMID:
22878095

Supplemental Content

Support Center